From CSV to CSA: What Pharma Companies Need to Know
The FDA's draft guidance on Computer Software Assurance signals a fundamental shift in how we validate computerized systems. Here's what the transition looks like in practice.
Read More →Perspectives on compliance, validation, and the future of pharma technology
The FDA's draft guidance on Computer Software Assurance signals a fundamental shift in how we validate computerized systems. Here's what the transition looks like in practice.
Read More →As machine learning enters pharma manufacturing and quality operations, the regulatory framework is catching up. A practical approach to AI system governance in regulated environments.
Read More →Data integrity isn't a checklist. It's an organizational capability. How leading pharma companies are embedding ALCOA+ principles into their operational DNA.
Read More →Validating SAP, Veeva, or LIMS isn't the same as validating a custom application. Enterprise platform validation requires a different strategy. Here's ours.
Read More →ICH Q9(R1) raised the bar for risk-based approaches. What that means for your validation strategy and how to operationalize it.
Read More →When your GxP system runs in someone else's data center, the validation model changes. Infrastructure qualification, shared responsibility, and what your vendor assessment should actually cover.
Read More →The regulation hasn't changed, but the technology landscape has. How to apply Part 11 to modern cloud architectures, SaaS platforms, and hybrid environments.
Read More →The 2022 update to GAMP 5 introduced critical thinking as a core principle and aligned with CSA. A practical breakdown of what changed and how to adopt it.
Read More →A CoE isn't just a shared services team. It's an operating model that standardizes validation across the enterprise. How to design, staff, and scale one.
Read More →